4//SEC Filing
Schuetz Thomas J. 4
Accession 0001171843-25-000831
CIK 0001738021other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:12 PM ET
Size
5.4 KB
Accession
0001171843-25-000831
Insider Transaction Report
Form 4
Schuetz Thomas J.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2025-02-11+1,500,000→ 1,500,000 totalExercise: $3.65Exp: 2035-02-11→ CommonStock (1,500,000 underlying)
Footnotes (1)
- [F1]The options vest over 48 substantially equal monthly installments starting March 11, 2025.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0001591464
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:12 PM ET
- Size
- 5.4 KB